ProPharma Group and The Planet Group announce unified brand and expanded capabilities. Learn more >

EMA Approval Under Exceptional Circumstances

You’ve developed a novel drug and obtained FDA approval. Your work is done, right? Not if you want to market your product outside the US. For many Sponsors, the logical next step is to enter the European market.

Where do you start? What data is needed and what can be repurposed from your FDA submission? How long will the process take? These are just a few of the many questions you probably have, but the good news is that ProPharma Group’s team of experienced regulatory experts is here to help.

Learn how our regulatory experts helped one client obtain EMA approval under exceptional circumstances using an innovative approach to working with the available BLA to make it fit for the purpose of the MAA submission.

Download Case Study

Contact Us



Your Business has Complex Challenges. ProPharma Group has Exceptional Solutions.

We partner with pharmaceutical, biotechnology, and medical device clients to tackle complex challenges. Contact us to learn how our experienced team can help ensure regulatory and development success throughout the product lifecycle.

Interested in gaining an industry edge? Let us help you stay up to date.


All fields are required.
There was a problem with your submission. Errors have been highlighted below.